|
|
Article: Millennium and Harvard Medical School Sign Cooperative Cancer Biology Agreement.
- Article from:
- BIOTECH Patent News
- Article date:
- February 1, 2008
CopyrightCOPYRIGHT 2008 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Millennium Pharmaceuticals, Inc. (Cambridge, MA) and Harvard Medical School's Office of Technology Development (Cambridge, MA) announced an innovative collaboration agreement to pursue a research program in the area of protein homeostasis, an emerging and expanding field of cancer biology. Under the terms of the agreement, Harvard has granted Millennium a license to certain invention from the laboratory of Professor J. Wade Harper and the two institutions will jointly advance the program in this novel area of research over several years under a sponsored research agreement. Financial terms were not disclosed.
"Harvard Medical School's research initiatives in ...
Related newspaper, magazine, and journal articles:
|
|
Article: Kaiser Permanente/Harvard Medical School ...
PR Newswire;
November 19, 2007 ;
700+ words
... ... by Kaiser Permanente and Harvard Medical School/Harvard Pilgrim Health ... Ambulatory Care and Prevention, Harvard Medical School/Harvard Pilgrim Health ... National Institutes of Health, Harvard Medical School and Harvard Pilgrim Health ...
|
|